Kymera IPO Presentation Deck

Nello Mainolfi, PhD Founder, President & Chief Executive Officer • Global project leader and co-inventor of LNP023- first SM factor B inhibitor • Inventor of LHA510- first topical SM for wet AMD & NOVARTIS KYMERA Richard Chesworth, PhD Chief Scientific Officer Head of Research and key contributor to the discovery and development of Tazverik Over 20 years of pharma and biotech experience CEpizyme Leadership Team Jared Gollob, MD Chief Medical Officer Development lead for Onpattro, First FDA approved RNAI medicine at ALNY 2 Alnylam Bruce Jacobs, CFA, MBA Chief Financial Officer Over 25 years in health care financial services, equity research and investment banking. WESTFIELD CAPITAL MANAGEMENT Karen Martin, PhD, JD Brian Albarran, PhD, MBA VP, Strategy VP, Head of Intellectual Property & Operations Over 15 years in intellectual property law, patent portfolio development, licensing, transactions, post-grant practice, litigation Takeda • Head of Cl; PTL for dostarlimab (anti-PD-1) • Over 14 years in R&D, BD, strategy consulting. and operations TESARO Paige Cochran VP, Human Resources Over 25 years of HR experience for both private and public high-growth companies in life science and technology verticals microchips

View entire presentation